Cargando…
Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights
Gastric cancer is a significant global health problem as it is the fifth most prevalent cancer worldwide and the fourth leading cause of cancer-related mortality. While cytotoxic chemotherapy remains the primary treatment for advanced GC, response rates are limited. Recent progresses, focused on mol...
Autores principales: | Chatterjee, Annesha, Azevedo-Martins, Jordana Maria, Stachler, Matthew D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424681/ https://www.ncbi.nlm.nih.gov/pubmed/37583706 http://dx.doi.org/10.2147/OTT.S389120 |
Ejemplares similares
-
Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis
por: Kato, Toru, et al.
Publicado: (2019) -
Interleukin-33 as a Potential Therapeutic Target for Interstitial Cystitis: New Perspectives on Mast Cell Regulation
por: Choo, Min Soo
Publicado: (2015) -
Clinical implications of interleukins-31, 32, and 33 in gastric cancer
por: Liu, Qing-Hua, et al.
Publicado: (2022) -
Gastric Cancer Stem Cells: Current Insights into the Immune Microenvironment and Therapeutic Targets
por: Fu, Lingfeng, et al.
Publicado: (2020) -
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
por: Sun, Yun, et al.
Publicado: (2021)